Clindazan

Main information

  • Trade name:
  • Clindazan 150 mg/mL (600 mg/4mL) Solution for Injection (IM/IV)
  • Dosage:
  • 150 mg/mL (600 mg/4mL)
  • Pharmaceutical form:
  • Solution for Injection (IM/IV)
  • Units in package:
  • 5mL (net content of 4mL) Type I clear, glass ampoule, individually packed per box (box of 10's)
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug
  • Manufactured by:
  • Vitrofarma S.A. Plant 8

Documents

Localization

  • Available in:
  • Clindazan 150 mg/mL (600 mg/4mL) Solution for Injection (IM/IV)
    Philippines
  • Language:
  • English

Status

  • Source:
  • FDA - Food And Drug Administration - Philippines
  • Authorization number:
  • DRP-2388-01
  • Authorization date:
  • 03-03-2021
  • Last update:
  • 26-01-2017